ArticleCancer chemotherapy and pharmacology2021

Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.

Xianglan Yi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.